The Burkina Faso government has introduced a state-of-the-art diagnostic tool, MammaTyper, to combat breast cancer. This technology provides results within six hours, a significant improvement over traditional methods. According to the World Cancer Observatory (Globocan), in 2024, Burkina Faso recorded 15,000 cancer cases, resulting in 10,000 deaths. Breast cancer accounted for over 2,100 cases, with 1,000 deaths, or approximately three female deaths per day.
The MammaTyper technology is a key component of the President's Initiative for Health (IPS), aimed at improving healthcare in Burkina Faso. The IPS, managed by the National Bureau of Large Projects (BN-GPB), has made this diagnostic tool available at the Bogodogo and Pala university hospitals. Professor Téné Marceline Yaméogo, Director of Medical and Technical Services, expressed her satisfaction with the initiative, highlighting its potential to support women with breast cancer.
Dr. Bruno Adjonba, a medical biologist at the Pala university hospital, explained the benefits of MammaTyper, stating that it proposes tailored treatments based on the molecular subtype of the cancer. This technology is a first in Africa and contributes to improved patient care with more accurate results. Dr. Adjonba and other medical professionals underwent training in Hamburg, Germany, to master the use of MammaTyper.
The introduction of MammaTyper in Burkina Faso is expected to reduce medical evacuations abroad. Dr. Valentin Konsegré, an anatomopathologist at the Pala university hospital, noted that this technology will eliminate the need for external subtyping. The Coordonnateur national de l'IPS, Drissa Traoré, visited the two university hospitals to verify the technology's functionality and expressed his satisfaction with the precise results obtained.
The test results have been validated by the platform that manages data interpretation and calculation. Dr. R. Alexie Ouédraogo, a lecturer in histology and genetics at the Bogodogo university hospital, confirmed that the technology is well-mastered by Burkinabè practitioners. The services offered are accessible to all Burkinabè citizens at subsidized rates.
The healthcare personnel at the Pala and Bogodogo university hospitals have expressed their gratitude to the President of Faso for his innovative vision and commitment to the well-being of the population. During the October Rose 2026 campaign, the Minister of Health encouraged women to undergo free breast cancer screening.
The availability of MammaTyper in Burkina Faso marks a significant step forward in the fight against breast cancer. With this technology, patients can receive timely and targeted treatments, improving their chances of recovery. The Burkinabè government has demonstrated its commitment to enhancing healthcare services, and the population is expected to benefit from this advanced diagnostic tool.
Key points
- * MammaTyper provides results within six hours, reducing treatment uncertainty and costs. * The technology is a first in Africa and has been introduced at two university hospitals in Burkina Faso. * The services offered are accessible to all Burkinabè citizens at subsidized rates.
